| 1 | The association and aggregation of the metamorphic chemokine lymphotactin with fondaparinux: from nm molecular complexes to μm molecular assemblies. (Harvey SR, MacPhee CE, Volkman BF, Barran PE) Chem Commun (Camb) 2016 Jan 07;52(2):394-7 4 Citations |
| 2 | Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation. (Fox JC, Tyler RC, Guzzo C, Tuinstra RL, Peterson FC, Lusso P, Volkman BF) ACS Chem Biol 2015 Nov 20;10(11):2580-8 22 Citations |
| 1 | Interplay of Electrostatics and Hydrophobic Effects in the Metamorphic Protein Human Lymphotactin. (Korkmaz EN, Volkman BF, Cui Q) J Phys Chem B 2015 Jul 30;119(30):9547-58 3 Citations |
| 1 | Electron capture dissociation and drift tube ion mobility-mass spectrometry coupled with site directed mutations provide insights into the conformational diversity of a metamorphic protein. (Harvey SR, Porrini M, Tyler RC, MacPhee CE, Volkman BF, Barran PE) Phys Chem Chem Phys 2015 Apr 28;17(16):10538-50 15 Citations |
| 1 | Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily. (Fox JC, Nakayama T, Tyler RC, Sander TL, Yoshie O, Volkman BF) Cytokine 2015 Feb;71(2):302-11 45 Citations |
| 1 | Dissecting the dynamic conformations of the metamorphic protein lymphotactin. (Harvey SR, Porrini M, Konijnenberg A, Clarke DJ, Tyler RC, Langridge-Smith PR, MacPhee CE, Volkman BF, Barran PE) J Phys Chem B 2014 Oct 30;118(43):12348-59 32 Citations |
| 3 | Interconversion between two unrelated protein folds in the lymphotactin native state. (Tuinstra RL, Peterson FC, Kutlesa S, Elgin ES, Kron MA, Volkman BF) Proc Natl Acad Sci U S A 2008 Apr 01;105(13):5057-62 229 Citations |
| 2 | An engineered second disulfide bond restricts lymphotactin/XCL1 to a chemokine-like conformation with XCR1 agonist activity. (Tuinstra RL, Peterson FC, Elgin ES, Pelzek AJ, Volkman BF) Biochemistry 2007 Mar 13;46(10):2564-73 50 Citations |
| 1 | Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies. (Wolfgang WJ, Miller TW, Webster JM, Huston JS, Thompson LM, Marsh JL, Messer A) Proc Natl Acad Sci U S A 2005 Aug 09;102(32):11563-8 130 Citations |
| 2 | Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin. (Peterson FC, Elgin ES, Nelson TJ, Zhang F, Hoeger TJ, Linhardt RJ, Volkman BF) J Biol Chem 2004 Mar 26;279(13):12598-604 71 Citations |
| 1 | Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. (Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD, Evans DB, Semenza GL, Ellis LM) Am J Pathol 2003 Sep;163(3):1001-11 146 Citations |
| 1 | Reactive oxygen species are critical mediators of coronary collateral development in a canine model. (Gu W, Weihrauch D, Tanaka K, Tessmer JP, Pagel PS, Kersten JR, Chilian WM, Warltier DC) Am J Physiol Heart Circ Physiol 2003 Oct;285(4):H1582-9 48 Citations |
| 1 | Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. (Matsunaga T, Warltier DC, Tessmer J, Weihrauch D, Simons M, Chilian WM) Am J Physiol Heart Circ Physiol 2003 Jul;285(1):H352-8 91 Citations |
| 1 | Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. (Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S, Silverstein RL, Rafii S, Mesri EA) Cancer Cell 2003 Feb;3(2):131-43 211 Citations |
| 1 | Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis. (Fujioka S, Sclabas GM, Schmidt C, Niu J, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ) Oncogene 2003 Mar 06;22(9):1365-70 152 Citations |
| 1 | Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. (Thomas JP, Arzoomanian RZ, Alberti D, Marnocha R, Lee F, Friedl A, Tutsch K, Dresen A, Geiger P, Pluda J, Fogler W, Schiller JH, Wilding G) J Clin Oncol 2003 Jan 15;21(2):223-31 227 Citations |
| 1 | The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. (Park JI, Strock CJ, Ball DW, Nelkin BD) Mol Cell Biol 2003 Jan;23(2):543-54 112 Citations |
| 1 | Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies. (Cortes J, Albitar M, Thomas D, Giles F, Kurzrock R, Thibault A, Rackoff W, Koller C, O'Brien S, Garcia-Manero G, Talpaz M, Kantarjian H) Blood 2003 Mar 01;101(5):1692-7 215 Citations |
| 1 | Clinical applications of cardiovascular angiogenesis. (Zimmerman MA, Selzman CH, Raeburn CD, Calkins CM, Barsness K, Harken AH) J Card Surg 2001;16(6):490-7 8 Citations |
| 1 | Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions. (Kuloğlu ES, McCaslin DR, Markley JL, Volkman BF) J Biol Chem 2002 May 17;277(20):17863-70 62 Citations |
| 1 | Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. (Doll JA, Reiher FK, Crawford SE, Pins MR, Campbell SC, Bouck NP) Prostate 2001 Dec 01;49(4):293-305 120 Citations |
| 1 | Monomeric solution structure of the prototypical 'C' chemokine lymphotactin. (Kuloglu ES, McCaslin DR, Kitabwalla M, Pauza CD, Markley JL, Volkman BF) Biochemistry 2001 Oct 23;40(42):12486-96 57 Citations |
| 1 | Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training. (Amaral SL, Papanek PE, Greene AS) Am J Physiol Heart Circ Physiol 2001 Sep;281(3):H1163-9 135 Citations |
| 1 | Angiogenesis in a patient with ischemic limb induced by intramuscular injection of vascular endothelial growth factor and fibrin platform. (Kipshidze N, Chekanov V, Chawla P, Shankar LR, Gosset JB, Kumar K, Hammen D, Gordon J, Keelan MH) Tex Heart Inst J 2000;27(2):196-200 24 Citations |
| 1 | Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. (Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ, Radinsky R) Clin Cancer Res 2000 May;6(5):1936-48 425 Citations |
| 1 | Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. (Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM) Circulation 2000 Dec 19;102(25):3098-103 200 Citations |
| 1 | Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat. (Dawson DW, Volpert OV, Pearce SF, Schneider AJ, Silverstein RL, Henkin J, Bouck NP) Mol Pharmacol 1999 Feb;55(2):332-8 137 Citations |
| 1 | Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium. (Weihrauch D, Tessmer J, Warltier DC, Chilian WM) Am J Physiol 1998 Sep;275(3):H969-76 39 Citations |
| 1 | Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. (Kellokumpu-Lehtinen P, Talpaz M, Harris D, Van Q, Kurzrock R, Estrov Z) Int J Cancer 1996 May 16;66(4):515-9 84 Citations |
| 1 | Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. (Estrov Z, Samal B, Lapushin R, Kellokumpu-Lehtinen P, Sahin AA, Kurzrock R, Talpaz M, Aggarwal BB) J Interferon Cytokine Res 1995 Oct;15(10):905-13 46 Citations |
| 1 | Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha. (Wetzler M, Estrov Z, Talpaz M, Kim KJ, Alphonso M, Srinivasan R, Kurzrock R) Cancer Res 1994 Apr 01;54(7):1837-42 39 Citations |
| 1 | The modulatory hematopoietic activities of leukemia inhibitory factor. (Estrov Z, Talpaz M, Wetzler M, Kurzrock R) Leuk Lymphoma 1992 Sep;8(1-2):1-7 2 Citations |
| 1 | LIF: not just a leukemia inhibitory factor. (Kurzrock R, Estrov Z, Wetzler M, Gutterman JU, Talpaz M) Endocr Rev 1991 Aug;12(3):208-17 88 Citations |
| 1 | Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-alpha, and TGF-beta. (Wetzler M, Talpaz M, Lowe DG, Baiocchi G, Gutterman JU, Kurzrock R) Exp Hematol 1991 Jun;19(5):347-51 86 Citations |
© 2024 Clinical & Translational Science Institute